Denmark· DK-28107093923
Lazcluze
A lazertinib product containing lazertinib, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Lazertinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EB09 (lazertinib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Lazertinib · ATC L01EB09
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lazertinib costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lazertinib · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$339.05
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Lazertinib
- Manufacturer
- Janssen-Cilag International NV
- Country
- Denmark (DK)
- ATC code
- L01EB09
- ATC class
- Lazertinib
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107093923
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01EB09
Lazertinib, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/899a4ec0-607e-47ce-8211-f0dcf0896647 GET /v1/drugs/899a4ec0-607e-47ce-8211-f0dcf0896647?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "80 mg",
"auth_role": "RAP",
"dk_drugid": "28107093923",
"substance": "Lazertinib",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45677"
}See everything about lazertinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.